MacroGenics
MGNX
137 hedge funds and large institutions have $1.42B invested in MacroGenics in 2020 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 39 increasing their positions, 46 reducing their positions, and 24 closing their positions.
433% more capital invested
Capital invested by funds: $266M → $1.42B (+$1.15B)
63% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 24
12.78% more ownership
Funds ownership: 91.86% → 104.64% (+13%)
12% more funds holding
Funds holding: 122 → 137 (+15)
2% more call options, than puts
Call options by funds: $5.63M | Put options by funds: $5.52M
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
15% less repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 46
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$79.6M |
| 2 |
CCM
Consonance Capital Management
New York
|
+$70.2M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$26.1M |
| 4 |
PA
Perceptive Advisors
New York
|
+$22.4M |
| 5 |
RI
RTW Investments
New York
|
+$21.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$19.4M |
| 2 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$12.8M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$10.8M |
| 4 |
UBS AM
Chicago,
Illinois
|
-$10.4M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$9.26M |
MGNX Hedge Fund Activity: Q2 2020 in Review
137 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q2 2020, worth a combined $1.42B — up 433% from $266M a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new MGNX positions and 24 closed out — a net gain of 15 holders — while 39 added to existing stakes and 46 trimmed.
The largest buyer was RA Capital Management, opening a new position worth an estimated $79.6M. The largest seller was Bellevue Group, cutting an estimated $19.4M.
- 137 institutional investors held MacroGenics (MGNX) as of Q2 2020, up from 122 in Q1 2020.
- Funds reported $1.42B of MacroGenics stock for Q2 2020, up 433% quarter-over-quarter.
- 39 funds opened new MacroGenics positions in Q2 2020 and 24 closed out, a net change of +15 holders.
- The largest MacroGenics buyer in Q2 2020 was RA Capital Management, an estimated $79.6M added.
- The largest MacroGenics seller in Q2 2020 was Bellevue Group, an estimated $19.4M sold.
Based on aggregated 13F filings for Q2 2020.